Status:
WITHDRAWN
Analysis of Impact on Nasal Obstruction by Commercially Available Internal Nasal Stents
Lead Sponsor:
Bethany L. Jones
Collaborating Sponsors:
Sanostec Corp.
Conditions:
Nasal Obstruction
Eligibility:
All Genders
18-80 years
Brief Summary
Commercially-available internal nasal stents placed inside the nostril should produce decreased nasal obstruction detectable subjectively (volunteers will fill out a survey) and objectively (degree of...
Detailed Description
Nasal rhinomanometry provides a measure of the airflow through the nose during inspiration and expiration. The effect of static obstructions, such as septal deviation, as well as dynamic obstructions,...
Eligibility Criteria
Inclusion
- 18 years or older
Exclusion
- history of nasal surgery, currently using topical nasal steroid spray, over the counter decongestant, history of recurrent epistaxis or history of nosebleed within 2 weeks prior to data collection, currently pregnant
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00683254
Start Date
May 1 2008
End Date
August 1 2008
Last Update
May 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa Department of Otolaryngology
Iowa City, Iowa, United States, 52242